Portfolio (Quarterly)
Guide ↗
TANG CAPITAL MANAGEMENT LLC
· CIK 0001232621| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | — | VENTYX BIOSCIENCES INC | — | 2,814,000.0 | $25.4M | 1.25% | -286K | -9.2% | $9.03 | — |
| 22 | NVDA | NVIDIA CORPORATION | Technology | 127,788.0 | $23.8M | 1.18% | -3K | -2.1% | $186.50 | +26.4% |
| 23 | PGEN | PRECIGEN INC | Healthcare | 5,617,500.0 | $23.5M | 1.16% | -6.8M | -54.7% | $4.18 | +10.0% |
| 24 | SPY | SPDR S&P 500 ETF TR | Financial Services | 30,000.0 | $20.5M | 1.01% | NEW | — | $681.92 | +8.4% |
| 25 | MRNA | MODERNA INC | Healthcare | 692,820.0 | $20.4M | 1.01% | +388K | +126.9% | $29.49 | +69.7% |
| 26 | VKTX | VIKING THERAPEUTICS INC | Healthcare | 500,000.0 | $17.6M | 0.87% | -370K | -42.5% | $35.18 | -9.9% |
| 27 | AVIR | ATEA PHARMACEUTICALS INC | Healthcare | 4,814,700.0 | $17.2M | 0.85% | — | — | $3.57 | +14.8% |
| 28 | STOK | STOKE THERAPEUTICS INC | Healthcare | 500,000.0 | $15.9M | 0.78% | — | — | $31.74 | -1.2% |
| 29 | IDYA | IDEAYA BIOSCIENCES INC | Healthcare | 450,000.0 | $15.6M | 0.77% | +50K | +12.5% | $34.57 | -16.6% |
| 30 | META | META PLATFORMS INC | Communication Services | 23,331.0 | $15.4M | 0.76% | -3K | -10.3% | $660.09 | -6.3% |
| 31 | GSK | GSK PLC | Healthcare | 300,000.0 | $14.7M | 0.73% | -100K | -25.0% | $49.04 | +3.9% |
| 32 | DERM | JOURNEY MED CORP | Healthcare | 1,854,596.0 | $14.3M | 0.71% | — | — | $7.71 | -17.9% |
| 33 | LENZ | LENZ THERAPEUTICS INC | Healthcare | 865,169.0 | $13.8M | 0.68% | -32K | -3.6% | $16.00 | -54.4% |
| 34 | PCVX | VAXCYTE INC | Healthcare | 275,000.0 | $12.7M | 0.63% | -25K | -8.3% | $46.14 | +16.0% |
| 35 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 264,692.0 | $10.9M | 0.54% | — | — | $41.21 | +107.1% |
| 36 | HRMY | HARMONY BIOSCIENCES HLDGS IN | Healthcare | 290,292.0 | $10.9M | 0.54% | +9K | +3.2% | $37.42 | -17.8% |
| 37 | BMY | BRISTOL-MYERS SQUIBB CO | Healthcare | 200,000.0 | $10.8M | 0.53% | NEW | — | $53.94 | +5.7% |
| 38 | INSM | INSMED INC | Healthcare | 60,000.0 | $10.4M | 0.52% | -140K | -70.0% | $174.04 | -33.6% |
| 39 | — | CRESCENT BIOPHARMA INC. | — | 872,398.0 | $10.3M | 0.51% | +193K | +28.3% | $11.86 | — |
| 40 | WVE | WAVE LIFE SCIENCES LTD | Healthcare | 600,000.0 | $10.2M | 0.50% | NEW | — | $17.00 | -59.4% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
96.6%
Technology
1.3%
Financial Services
1.1%
Communication Services
0.9%
Real Estate
0.1%